Second Genome Strengthens R&D Program in Immuno-Oncology with Four Academic Collaborations

February 28, 2018, Feb. 28, 2018

Read More

Second Genome Advances Lead, Oral Small Molecule SGM-1019, Toward Clinical Investigation in NASH After Demonstrating Safety and Tolerability in Phase 1 Study

December 19, 2017, SOUTH SAN FRANCISCO, Calif., Dec 19, 2018

Read More

Second Genome Launches Study of the Relationship Between Microbiome and Central Nervous System in Autism Spectrum Disorders

October 3, 2017,

Read More

Second Genome Named Technology Pioneer by World Economic Forum

June 4, 2017,

Read More

Second Genome Announces Appointments in Human Resources, Finance to Support Corporate Growth

December 7, 2016, South San Francisco, CA

Read More

Second Genome Partners with King’s College London to Evaluate the Influence of the Microbiome in Landmark EAT Study

October 11, 2016, South San Francisco, CA

Read More

Monsanto Collaborates with Second Genome to use Microbiome Technology Platform to Accelerate Protein Discovery

September 6, 2016, St. Louis, MO and South San Francisco, CA

Read More

Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer

July 13, 2016, South San Francisco, CA

Read More